Markets:

Overview

News

Currencies

International

Treasuries

Articles published by QPS Holdings, LLC

QPS Selects Oracle Argus Safety Database to Enhance Pharmacovigilance in Clinical Trials

January 15, 2026

From QPS Holdings, LLC

Via Business Wire

QPS Celebrates 30th Anniversary

June 04, 2025

From QPS Holdings, LLC

Via Business Wire

QPS India Successfully Completes Week-Long US FDA Regulatory Inspection

May 01, 2025

From QPS Holdings, LLC

Via Business Wire

QPS Expands Offerings With Robust Pharmacology Disease Models, Including MASH, Ulcerative Colitis, Wound Healing, and Psoriasis

April 23, 2025

From QPS Holdings, LLC

Via Business Wire

QPS Launches New Leukopak and Cell Therapy Products Facility

November 13, 2024

From QPS Holdings, LLC

Via Business Wire

QPS Announces New Laboratory Services for Clinical Trials and Cell Therapy Development

June 26, 2024

From QPS Holdings, LLC

Via Business Wire

QPS Announces New Global Clinical Research Operations Leadership

June 20, 2024

From QPS Holdings, LLC

Via Business Wire

QPS Expands Clinic in Miami, Florida to Accommodate Increasing Demand for Obesity Trials

May 21, 2024

From QPS Holdings, LLC

Via Business Wire

QPS Significantly Enhances Mass Spectrometry Laboratory Capacity

January 10, 2024

From QPS Holdings, LLC

Via Business Wire

QPS Continues UPLC-HRMS Expansion Into Europe to Support Gene Therapy and Protein Drug Development

December 14, 2023

From QPS Holdings, LLC

Via Business Wire

QPS Holdings, LLC Expands Operations in Springfield, Missouri

December 04, 2023

From QPS Holdings, LLC

Via Business Wire

QPS Holdings, LLC divests its Neuropharmacology Business Unit

November 30, 2023

From QPS Holdings, LLC

Via Business Wire

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Articles published by QPS Holdings, LLC

Starting at $3.75/week.

Subscribe Today